Michael F. Roman

Michael F. Roman

Executive Advisor to the Board and Former Executive Chairman of the Boardat3M· In proxies 2017–2024

Pay in FY2024+5% from the year before

Michael F. Roman was paid $17.2M in FY2024 (Dec), up 5%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each 3M proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. 3MPublic company · 9 yr
    • Executive Advisor to the Board and Former Executive Chairman of the Board2017 – Present · 9 yrNo stock prices for these years
  2. Abbott LaboratoriesPublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards2

  • 3MChair · 4 yr on the boardNot independent—Paid as an executive
  • Abbott LaboratoriesDirector · 2 yr on the boardIndependentCompensation, Executive, Public Policy (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?